Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000020

Chief Scientific Officer bought 4,549 shares at $2.85 ($12,953)

From the SEC's structured data for this filing

Trades in this filing

Calias Pericles · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-10 Purchase : show line 1 in the form +4,549 $2.85 $12,953 49,549 D
Open-market purchases · 4,549 sh · avg $2.85 · $12,953
Loading xslF345X03/primary_doc.xml…